1
|
Caffrey N, Goldman M, Lewin A, Grégoire Y, Yi QL, O'Brien SF. Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data. Transfus Clin Biol 2022; 29:198-204. [PMID: 35987531 DOI: 10.1016/j.tracli.2022.06.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Revised: 06/01/2022] [Accepted: 06/05/2022] [Indexed: 10/15/2022]
Abstract
OBJECTIVE Gay, bisexual and other men who have sex with men (gbMSM) were ineligible to donate blood in most countries since the 1980's. In Canada the deferral period has been incrementally decreased from lifetime to male-to-male sex in the last 3 months. Now a few countries have removed the deferral altogether. Risk models have been utilised to estimate the probability of an HIV positive donation being released into the blood supply and to inform incremental changes to the length of the deferral period. Here we use public health data to estimate the risk of HIV if the gbMSM deferral criteria were removed in Canada. MATERIAL AND METHODS We calculate the risk reduction among heterosexuals based on responses to standard risk questions routinely asked of donors. We assume gbMSM will donate at the same rate as heterosexual males. We apply the same risk reduction principle to HIV incidence and prevalence among gbMSM in the general population to evaluate the HIV risk without gbMSM time deferral. We model three scenarios where risk reduction is varied by assumptions about incidence and compliance with deferral criteria. RESULTS The estimates for all scenarios were not significantly different to the currently observed scenario which predicts a residual risk of 0.02 HIV positive per million donations (95% CI: 0.000006-0.09). CONCLUSION The models predict that removing the gbMSM deferral criteria would result in HIV residual risk similar to currently observed.
Collapse
Affiliation(s)
- N Caffrey
- Donation Policy & Studies, Canadian Blood Services, K1G 4J5 Ottawa, ON, Canada.
| | - M Goldman
- Donation Policy & Studies, Canadian Blood Services, K1G 4J5 Ottawa, ON, Canada; Department of Pathology and Laboratory Medicine, University of Ottawa, K1H 8M5 Ottawa, Ontario, Canada.
| | - A Lewin
- Medical Affairs & Innovation, Héma-Québec 4045, boulevard de la Côte-Vertu, H4R 2W7 Saint-Laurent, QC, Canada.
| | - Y Grégoire
- Medical Affairs & Innovation, Héma-Québec 4045, boulevard de la Côte-Vertu, H4R 2W7 Saint-Laurent, QC, Canada.
| | - Q-L Yi
- Donation Policy & Studies, Canadian Blood Services, K1G 4J5 Ottawa, ON, Canada.
| | - S F O'Brien
- Donation Policy & Studies, Canadian Blood Services, K1G 4J5 Ottawa, ON, Canada; School of Epidemiology and Public Health, University of Ottawa, K1G 5Z3 Ottawa, Ontario, Canada.
| |
Collapse
|
2
|
Schoser B, Bratkovic D, Byrne B, Díaz-Manera J, Laforet P, Mozaffar T, van der Ploeg A, Roberts M, Toscano A, Jiang H, Sitaraman S, Kuchipudi S, Goldman M, Castelli J, Kishnani P. POMPE DISEASE. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
3
|
Brenton J, Banwell B, Bergqvist C, Lehner-Gulotta D, Leytham E, Gampper L, Goldman M, Coleman R. Application of a Modified Ketogenic Diet in Relapsing-Remitting Multiple Sclerosis Subjects. J Acad Nutr Diet 2019. [DOI: 10.1016/j.jand.2019.06.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
4
|
Abstract
SummaryThe measurement of platelet deposition in human thrombi is essential for the evaluation of platelet-inhibitory drugs and prosthetic materials for use in patients. The rate of 111Indiumlabelled platelet accumulation on Dacron arterial grafts was measured in 27 patients randomised to take either aspirin and dipyridamole (ASA + DPM) or placebo. Autologous platelets were labelled and re-injected seven days following surgery and the graft thrombogenidty index calculated as the daily rise in the ratio of emissions from the graft over a reference site.The mean (± SD) thrombogenidty index in 12 patients undergoing femoro-popliteal bypass was 0.25 ± 0.09 on placebo and 0.16 ± 0.07 on ASA + DPM started pre-operatively (p Ã0.05). Post-operative ASA + DPM therapy started two days following platelet labelling in 15 patients with aorto-femoral grafts also significantly reduce thrombogenidty to 0.12 ± 0.05 compared with 0.25 ± 0.08 on placebo (p Ã0.01). In the latter patients the ratio of emissions from the graft over reference fell significantly on starting ASA + DPM, suggesting a net loss of platelets from the graft. These results indicate that the rate of in vivo platelet accumulation on Dacron grafts can be quantitated and that ASA + DPM reduced this rate in man.
Collapse
Affiliation(s)
- H C Norcott
- The Departments of Surgery and Nuclear Medicine, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, England
| | - M Goldman
- The Departments of Surgery and Nuclear Medicine, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, England
| | - R J Hawker
- The Departments of Surgery and Nuclear Medicine, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, England
| | - E I Rafiqi
- The Departments of Surgery and Nuclear Medicine, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, England
| | - Z Drolc
- The Departments of Surgery and Nuclear Medicine, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, England
| | - C N McCollum
- The Departments of Surgery and Nuclear Medicine, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, England
| |
Collapse
|
5
|
Vereerstraeten P, Andrien M, Dupont E, Abramowicz D, de Pauw L, Goldman M, Kinnaert P. Detrimental role of donor-recipient HLA-DQ5
and -DQ6
disparities on cadaver kidney graft survival. Transpl Int 2018. [DOI: 10.1111/tri.1992.5.s1.143] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
6
|
De Backer D, Abramowicz D, Goldman M, De Pauw L, Viseur P, Vanherweghem JL, Kinnaert P, Vereerstraeten P. High or low dose steroid therapy for acute renal transplant rejection after prophylactic OKT3 treatment: a prospective randomized study. Transpl Int 2018. [DOI: 10.1111/tri.1992.5.s1.437] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Goldman M, Lagmiche M, Dhaene M, Amraoui Z, Thayse C, Vanherweghem JL. Adsorption of ß2-Microglobulin on Dialysis Membranes: Comparison of Different Dialyzers and Effects of Reuse Procedures. Int J Artif Organs 2018. [DOI: 10.1177/039139888901200605] [Citation(s) in RCA: 41] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
In order to measure ß2-microglobulin adsorption on dialysis membranes, uremic plasma was passed through different dialyzers in a simulated hemodialysis circuit in which both plasma and dialysate compartments were organized as closed loops, the ultrafiltration pressure being adjusted to minimize water shifts. Under these conditions, comparison of the amounts of ß2-m in the plasma and dialysate compartments allowed us to calculate the binding of ß2-m to the membrane at different times of the procedure. Whereas cuprophane membrane (Gambro gf 180m, 1.8m2) did not bind ß2-m, AN69 (Filtral, 1.1 m2), high flux polysulfone (F60, 1.2m2) and modified polyamide (Polyflux 130, Gambro, 1.3m2) were found to adsorb 49 ± 8 mg (mean ± SEM), 17 ± 5 mg and 38 ± 4 mg of 82-m, respectively. These data were confirmed in trace labeling experiments with 125I-ß2-m. Adsorption was a saturable phenomenon occurring during the first 90 min of in vitro dialysis. After reuse with peracetic acid, the adsorption capacity of AN69 membrane was lowered to 20 ± 4 mg of ß2-m, contrasting with the unchanged adsorption after reuse with sodium hypochlorite. These data indicate that adsorption significantly contributes to ß2-m removal during hemodialysis with certain dialyzers and that reuse procedures may affect the propensity of dialysis membranes to bind 82-m.
Collapse
Affiliation(s)
- M. Goldman
- Department of Nephrology, Dialysis and Transplantation, Cliniques Universitaires de Bruxelles, Hôpital Erasme and Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Université Libre de Bruxelles - Belgium
| | - M. Lagmiche
- Department of Nephrology, Dialysis and Transplantation, Cliniques Universitaires de Bruxelles, Hôpital Erasme and Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Université Libre de Bruxelles - Belgium
| | - M. Dhaene
- Department of Nephrology, Dialysis and Transplantation, Cliniques Universitaires de Bruxelles, Hôpital Erasme and Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Université Libre de Bruxelles - Belgium
| | - Z. Amraoui
- Department of Nephrology, Dialysis and Transplantation, Cliniques Universitaires de Bruxelles, Hôpital Erasme and Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Université Libre de Bruxelles - Belgium
| | - C. Thayse
- Department of Nephrology, Dialysis and Transplantation, Cliniques Universitaires de Bruxelles, Hôpital Erasme and Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Université Libre de Bruxelles - Belgium
| | - J.-L. Vanherweghem
- Department of Nephrology, Dialysis and Transplantation, Cliniques Universitaires de Bruxelles, Hôpital Erasme and Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Université Libre de Bruxelles - Belgium
| |
Collapse
|
8
|
Chipps BE, Newbold P, Hirsch I, Trudo F, Goldman M. Efficacy of Benralizumab for Patients with Severe, Uncontrolled Atopic Asthma by Serum Immunoglobulin E Concentrations. Pneumologie 2018. [DOI: 10.1055/s-0037-1619154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- BE Chipps
- Capital Allergy and Respiratory Disease Center, Sacramento, CA, USA
| | - P Newbold
- Medimmune LLC, Gaithersburg, MD, USA
| | - I Hirsch
- Astrazeneca, Gaithersburg, MD, USA
| | - F Trudo
- Astrazeneca, Gaithersburg, MD, USA
| | | |
Collapse
|
9
|
Newbold P, Hirsch I, Trudo F, Goldman M. Effects of Immunoglobin E Concentration, Eosinophil Concentration, and Atopy Status on Benralizumab Efficacy in Asthma. Pneumologie 2018. [DOI: 10.1055/s-0037-1619152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
| | | | - F Trudo
- Astrazeneca, Gaithersburg, USA
| | | |
Collapse
|
10
|
Roskos L, Wang B, Yan L, Yu B, Barker P, Goldman M. Longitudinal Modeling of Prebronchodilator FEV1 Response to Benralizumab for Patients with Severe Asthma. Pneumologie 2018. [DOI: 10.1055/s-0037-1619155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- L Roskos
- Medimmune LLC, Mountain View, CA, USA
| | - B Wang
- Medimmune LLC, Mountain View, CA, USA
| | - L Yan
- Medimmune LLC, Mountain View, CA, USA
| | - B Yu
- Medimmune LLC, Mountain View, CA, USA
| | - P Barker
- Astrazeneca, Gaithersburg, MD, USA
| | | |
Collapse
|
11
|
Roskos L, Wang B, Chia YL, Yu B, Barker P, Goldman M. Relationship between Benralizumab Exposure and Asthma Exacerbation Rate for Patients with Severe Asthma. Pneumologie 2018. [DOI: 10.1055/s-0037-1619156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- L Roskos
- Medimmune LLC, Mountain View, CA, USA
| | - B Wang
- Medimmune LLC, Mountain View, CA, USA
| | - YL Chia
- Medimmune LLC, Mountain View, CA, USA
| | - B Yu
- Medimmune LLC, Mountain View, CA, USA
| | - P Barker
- Astrazeneca, Gaithersburg, MD, USA
| | | |
Collapse
|
12
|
Ostinelli J, Roskos L, Wang B, Yan L, Yu B, Barker P, Goldman M. Modélisation longitudinale de la réponse sur le VEMS pre-bronchodilateur (preBD) de benralizumab chez des patients ayant un asthme sévère. Rev Mal Respir 2018. [DOI: 10.1016/j.rmr.2017.10.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
13
|
Ji X, Can TV, Mentink-Vigier F, Bornet A, Milani J, Vuichoud B, Caporini MA, Griffin RG, Jannin S, Goldman M, Bodenhausen G. Overhauser effects in non-conducting solids at 1.2 K. J Magn Reson 2018; 286:138-142. [PMID: 29241045 PMCID: PMC5767554 DOI: 10.1016/j.jmr.2017.11.017] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/05/2017] [Revised: 11/23/2017] [Accepted: 11/26/2017] [Indexed: 05/05/2023]
Abstract
Recently, it was observed that protons in non-conducting solids doped with 1,3-bisdiphenylene-2-phenylallyl (BDPA) or its sulfonated derivative (SA-BDPA) can be polarized through Overhauser effects via resonant microwave irradiation. These effects were present under magic angle spinning conditions in magnetic fields between 5 and 18.8 T and at temperatures near 100 K. This communication reports similar effects in static samples at 6.7 T and, more importantly, at temperatures as low as 1.2 K, in a different dynamic regime than in the previous study. Our results provide new information towards understanding the mechanism of the Overhauser effect in non-conducting solids. We discuss possible origins of the fluctuations that can give rise to an Overhauser effect at such low temperatures.
Collapse
Affiliation(s)
- X Ji
- Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Departement de Chimie, Ecole Normale Superieure, PSL Research University, UPMC Univ Paris 06, CNRS, Laboratoire des Biomolecules (LBM), 24 rue Lhomond, 75005 Paris, France; Sorbonne Universites, UPMC Univ Paris 06, Ecole Normale Superieure, CNRS, Laboratoire des Biomolecules (LBM), Paris, France
| | - T V Can
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Francis Bitter Magnet Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - F Mentink-Vigier
- National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL 32310, USA
| | - A Bornet
- Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Univ Lyon, CNRS, Université Claude Bernard Lyon 1, ENS de Lyon, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, 69100 Villeurbanne, France
| | - J Milani
- Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Univ Lyon, CNRS, Université Claude Bernard Lyon 1, ENS de Lyon, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, 69100 Villeurbanne, France
| | - B Vuichoud
- Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Univ Lyon, CNRS, Université Claude Bernard Lyon 1, ENS de Lyon, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, 69100 Villeurbanne, France
| | - M A Caporini
- Amgen Inc., 360 Binney Street Cambridge, MA 02142, USA
| | - R G Griffin
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Francis Bitter Magnet Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
| | - S Jannin
- Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Univ Lyon, CNRS, Université Claude Bernard Lyon 1, ENS de Lyon, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, 69100 Villeurbanne, France
| | - M Goldman
- 2 Allée Geneviève Anthonioz de Gaulle, 93260 Les Lilas, France
| | - G Bodenhausen
- Departement de Chimie, Ecole Normale Superieure, PSL Research University, UPMC Univ Paris 06, CNRS, Laboratoire des Biomolecules (LBM), 24 rue Lhomond, 75005 Paris, France; Sorbonne Universites, UPMC Univ Paris 06, Ecole Normale Superieure, CNRS, Laboratoire des Biomolecules (LBM), Paris, France.
| |
Collapse
|
14
|
Goldman M, W-Y Shih A, O'Brien SF, Devine D. Donor deferral policies for men who have sex with men: past, present and future. Vox Sang 2017; 113:95-103. [DOI: 10.1111/vox.12623] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Revised: 11/14/2017] [Accepted: 11/14/2017] [Indexed: 11/29/2022]
Affiliation(s)
- M. Goldman
- Canadian Blood Services; Ottawa ON Canada
| | - A. W-Y Shih
- Vancouver General Hospital; Vancouver BC Canada
| | | | - D. Devine
- Canadian Blood Services; Vancouver BC Canada
| |
Collapse
|
15
|
Chipps B, Newbold P, Hirsch I, Trudo F, Goldman M. P221 Efficacy of benralizumab for patients with severe, uncontrolled atopic asthma by serum immunoglobulin E concentrations. Ann Allergy Asthma Immunol 2017. [DOI: 10.1016/j.anai.2017.08.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
Newbold P, Hirsch I, Trudo F, Goldman M. P222 Effects of immunoglobulin e concentration, eosinophil concentration, and atopy status on benralizumab efficacy in asthma. Ann Allergy Asthma Immunol 2017. [DOI: 10.1016/j.anai.2017.08.260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
17
|
Affiliation(s)
- M. Goldman
- Canadian Blood Services; Ottawa ON Canada
| | | |
Collapse
|
18
|
Engelfriet C, Reesink H, Barbolla L, Carbonell F, Mitchell R, Contreras M, Knight R, Goldman M, Décary F, Garraty G, Gerber H, Hustings H, Kornstad L, Moulds J, Overbeeke M, Pirkola A, Voak D, Ouwehand W. What Is the Best Technique for the Detection of Red Cell Alloantibodies? Vox Sang 2017. [DOI: 10.1159/000462857] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
19
|
Abstract
This paper analyses two stories by Alice Munro to explore how her fiction interrogates the prevailing social imaginary of the fourth age. Drawing on the theory of Gilleard and Higgs, I show how Munro's stories rely on irony and surreal imagery to subvert the logic that engenders and normalises the opposition between the third and fourth ages, and, by extension, the social death of people coping with later-life dementia. Ultimately, I argue that Munro's fiction does not so much reveal the Truth about the fourth age, as expose the reader's complicity in the construction of the prevailing gothic social imaginary.
Collapse
|
20
|
Affiliation(s)
- S. F. O'Brien
- Canadian Blood Services; Ottawa ON Canada
- School of Epidemiology, Public Health and Preventive Medicine; University of Ottawa; Ottawa ON Canada
| | - M. Goldman
- Canadian Blood Services; Ottawa ON Canada
- Department of Pathology & Laboratory Medicine; University of Ottawa; Ottawa ON Canada
| |
Collapse
|
21
|
Chen L, Goldman M, Mak J, Hsue P, Vittinghoff E, Jacoby V. Risk Reducing Salpingooophorectomy Versus Ovarian Preservation Among BRCA Mutation Carriers. Gynecol Oncol 2016. [DOI: 10.1016/j.ygyno.2016.08.256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
22
|
Goldman M, Magnussen K, Gorlin J, Lozano M, Speedy J, Keller A, Pink J, Leung JNS, Chu CCY, Lee CK, Faed J, Chay J, Tan HH, Teo D, Djoudi R, Woimant G, Fillet AM, Castrén J, Miflin G, Vandewalle GC, Compernolle V, Cardenas JM, Infanti L, Holbro A, Buser A, van den Hurk K, Yahalom VJ, Gendelman V, Shinar E, Eder AF, Steele WR, O'Neill EM, Kamel H, Vassallo R, Delage G, Lebrun A, Robillard P, Germain M, Gandhi M, West KA, Klein HG. International Forum regarding practices related to donor haemoglobin and iron. Vox Sang 2016; 111:449-455. [DOI: 10.1111/vox.12431] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- M. Goldman
- Medical Services and Innovation; Canadian Blood Services; Ottawa ON Canada
| | - K. Magnussen
- Clinical Immunology/Blood Centre; Copenhagen University Hospital; Hvidovre Denmark
| | - J. Gorlin
- Physician Services; Innovative Blood Centers; St. Paul MN USA
| | - M. Lozano
- Hospital Clinic; Department of Hemotherapy and Hemostasis; Barcelona Spain
| | - J. Speedy
- Australian Red Cross Blood Service; Adelaide South Australia Australia
| | - A. Keller
- Australian Red Cross; Perth Western Australia Australia
| | - J. Pink
- Australian Red Cross Blood Service; Stafford Queensland Australia
| | - J. N. S. Leung
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - C. C. Y. Chu
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - C.-K. Lee
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - J. Faed
- Otago Site, New Zealand Blood Service; Department of Haematology; University of Otago; Dunedin New Zealand
| | - J. Chay
- Blood Services Group; Health Sciences Authority; 11 Outram Road Singapore City 169078 Singapore
| | - H. H. Tan
- Blood Services Group; Health Sciences Authority; 11 Outram Road Singapore City 169078 Singapore
| | - D. Teo
- Centre for Transfusion Medicine; Singapore City Singapore
| | - R. Djoudi
- Qualification Biologique du Don; Etablissement Français du Sang; St. Denis France
| | - G. Woimant
- EFS, Médecine, la Recherche et l'Innovation; La Plaine Saint-Denis France
| | - A.-M. Fillet
- Medical Department; Etablisement Français du Sang; 20 Avenue du Stade de France La Plaine Saint-Denis 93218 France
| | - J. Castrén
- Medical Support in Blood Donation; Finnish Red Cross Blood Service; Kivihaantie 7 Helsinki FI-00310 Finland
| | - G. Miflin
- NHS Blood and Transplant; Watford UK
| | | | - V. Compernolle
- Blood Services; Belgian Red Cross; Ottergemsesteenweg 413 Ghent B-9000 Belgium
| | - J. M. Cardenas
- Tejidos Humanos; Centro Vasco de Transfusion y Tejidos Humanos; Labeaga s/n Galdakao 48960 Spain
| | - L. Infanti
- Blood Donation Center; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
| | - A. Holbro
- Blood Transfusion Centre; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
- Department of Hematology; University Hospital Basel; Basel Switzerland
| | - A. Buser
- Blood Transfusion Centre; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
- Department of Hematology; University Hospital Basel; Basel Switzerland
| | - K. van den Hurk
- Donor Studies; Sanquin Research; Plesmanlaan 125 Amsterdam 1066 CX The Netherlands
| | - V. J. Yahalom
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - V. Gendelman
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - E. Shinar
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - A. F. Eder
- Biomedical Headquarters; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - W. R. Steele
- Transmissible Disease Department; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - E. M. O'Neill
- National Headquarters; Biomedical Services; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - H. Kamel
- Medical Affairs; Blood Systems, Inc.; 6210 E. Oak Street Scottsdale AZ 85257 USA
| | - R. Vassallo
- Blood Systems, Inc.; 6210 E. Oak Street Scottsdale AZ 85257 USA
| | - G. Delage
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - A. Lebrun
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - P. Robillard
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - M. Germain
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - M. Gandhi
- Laboratory of Medicine and Pathology; Mayo Clinic Minnesota; 200 1st Street SW Rochester MN 55905 USA
| | - K. A. West
- Department of Transfusion Medicine; National Institutes of Health Clinical Center; 10 Center Drive, Room 1N226 Bethesda MD 20892 USA
| | - H. G. Klein
- Department of Transfusion Medicine; National Institute of Health; Warren G. Magnuson Clinical Center; 10 Center Drive, Room IC711 Bethesda MD 20892 USA
| |
Collapse
|
23
|
Abstract
Background: The purpose of this study was to examine quantitatively the effect of compression stockings on venous haemodynamics at the level of the ankle. Methods: To obtain quantifiable results, a computer-controlled photoplethysmographic system was used to measure the displacement of local blood volume induced by exercise (exercise displacement volume, EDV) and by tilting the subject (tilt displacement volume, TDV). The test was repeated after application of class I compression stockings 20–30 mmHg). The ratio EDV/TDV is considered to represent the efficiency of the veno-muscular pump. Three groups of subjects were studied: a control group ( n = 8), patients with telangiectases ( n = 10) and a group with large varices ( n = 11). Results: The application of external compression had a quantifiable and beneficial effect on venous haemodynamics and was most significantly documented by an increase in veno-muscular efficiency (EDV/TDV) from 28% to 44% in the varicose vein patients. Statistically significant increases of EDV/TDV could also be identified in the telangiectatic patients and normal subjects. EDV also showed an increase with compression stockings; however, statistical significance was only reached in the varicose vein group. Conclusion: External compression (class 1 compression stockings) significantly improved venous haemodynamic indices, especially in patients with varicose veins. Quantitative photoplethysmography used in this study permits a fast, non-invasive and quantifiable evaluation of venous haemodynamics of the lower extremities.
Collapse
Affiliation(s)
- A. Fronek
- Department of Surgery, University of California San Diego, La Jolla, California, USA
- Department of Bioengineering, University of California San Diego, La Jolla, California, USA
| | - M. Goldman
- Department of Dermatology, University of California San Diego, La Jolla, California, USA
| | - K. Fronek
- Department of Bioengineering, University of California San Diego, La Jolla, California, USA
| |
Collapse
|
24
|
Wissing M, Dubois C, Abramowicz D, Goldman M. Abstracts of the meeting of the Belgian Society of Nephrology (11 June 1994). Acta Clin Belg 2016. [DOI: 10.1080/17843286.1995.11718444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
25
|
Burch JL, Torbert RB, Phan TD, Chen LJ, Moore TE, Ergun RE, Eastwood JP, Gershman DJ, Cassak PA, Argall MR, Wang S, Hesse M, Pollock CJ, Giles BL, Nakamura R, Mauk BH, Fuselier SA, Russell CT, Strangeway RJ, Drake JF, Shay MA, Khotyaintsev YV, Lindqvist PA, Marklund G, Wilder FD, Young DT, Torkar K, Goldstein J, Dorelli JC, Avanov LA, Oka M, Baker DN, Jaynes AN, Goodrich KA, Cohen IJ, Turner DL, Fennell JF, Blake JB, Clemmons J, Goldman M, Newman D, Petrinec SM, Trattner KJ, Lavraud B, Reiff PH, Baumjohann W, Magnes W, Steller M, Lewis W, Saito Y, Coffey V, Chandler M. Electron-scale measurements of magnetic reconnection in space. Science 2016; 352:aaf2939. [PMID: 27174677 DOI: 10.1126/science.aaf2939] [Citation(s) in RCA: 438] [Impact Index Per Article: 54.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2016] [Accepted: 05/03/2016] [Indexed: 11/02/2022]
Abstract
Magnetic reconnection is a fundamental physical process in plasmas whereby stored magnetic energy is converted into heat and kinetic energy of charged particles. Reconnection occurs in many astrophysical plasma environments and in laboratory plasmas. Using measurements with very high time resolution, NASA's Magnetospheric Multiscale (MMS) mission has found direct evidence for electron demagnetization and acceleration at sites along the sunward boundary of Earth's magnetosphere where the interplanetary magnetic field reconnects with the terrestrial magnetic field. We have (i) observed the conversion of magnetic energy to particle energy; (ii) measured the electric field and current, which together cause the dissipation of magnetic energy; and (iii) identified the electron population that carries the current as a result of demagnetization and acceleration within the reconnection diffusion/dissipation region.
Collapse
Affiliation(s)
- J L Burch
- Southwest Research Institute, San Antonio, TX, USA.
| | - R B Torbert
- Southwest Research Institute, San Antonio, TX, USA. University of New Hampshire, Durham, NH, USA
| | - T D Phan
- University of California, Berkeley, CA, USA
| | - L-J Chen
- University of Maryland, College Park, MD, USA
| | - T E Moore
- NASA, Goddard Space Flight Center, Greenbelt, MD, USA
| | - R E Ergun
- University of Colorado LASP, Boulder, CO, USA
| | - J P Eastwood
- Blackett Laboratory, Imperial College London, London, UK
| | - D J Gershman
- NASA, Goddard Space Flight Center, Greenbelt, MD, USA
| | - P A Cassak
- West Virginia University, Morgantown, WV, USA
| | - M R Argall
- University of New Hampshire, Durham, NH, USA
| | - S Wang
- University of Maryland, College Park, MD, USA
| | - M Hesse
- NASA, Goddard Space Flight Center, Greenbelt, MD, USA
| | - C J Pollock
- NASA, Goddard Space Flight Center, Greenbelt, MD, USA
| | - B L Giles
- NASA, Goddard Space Flight Center, Greenbelt, MD, USA
| | - R Nakamura
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - B H Mauk
- Johns Hopkins University Applied Physics Laboratory, Laurel, MD, USA
| | - S A Fuselier
- Southwest Research Institute, San Antonio, TX, USA
| | - C T Russell
- University of California, Los Angeles, CA, USA
| | | | - J F Drake
- University of Maryland, College Park, MD, USA
| | - M A Shay
- University of Delaware, Newark, DE, USA
| | | | | | - G Marklund
- Royal Institute of Technology, Stockholm, Sweden
| | - F D Wilder
- University of Colorado LASP, Boulder, CO, USA
| | - D T Young
- Southwest Research Institute, San Antonio, TX, USA
| | - K Torkar
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - J Goldstein
- Southwest Research Institute, San Antonio, TX, USA
| | - J C Dorelli
- NASA, Goddard Space Flight Center, Greenbelt, MD, USA
| | - L A Avanov
- NASA, Goddard Space Flight Center, Greenbelt, MD, USA
| | - M Oka
- University of California, Berkeley, CA, USA
| | - D N Baker
- University of Colorado LASP, Boulder, CO, USA
| | - A N Jaynes
- University of Colorado LASP, Boulder, CO, USA
| | | | - I J Cohen
- Johns Hopkins University Applied Physics Laboratory, Laurel, MD, USA
| | - D L Turner
- Aerospace Corporation, El Segundo, CA, USA
| | | | - J B Blake
- Aerospace Corporation, El Segundo, CA, USA
| | - J Clemmons
- Aerospace Corporation, El Segundo, CA, USA
| | - M Goldman
- University of Colorado, Boulder, CO, USA
| | - D Newman
- University of Colorado, Boulder, CO, USA
| | - S M Petrinec
- Lockheed Martin Advanced Technology Center, Palo Alto, CA, USA
| | | | - B Lavraud
- Institut de Recherche en Astrophysique et Planétologie, Toulouse, France
| | - P H Reiff
- Department of Physics and Astronomy, Rice University, Houston, TX, USA
| | - W Baumjohann
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - W Magnes
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - M Steller
- Space Research Institute, Austrian Academy of Sciences, Graz, Austria
| | - W Lewis
- Southwest Research Institute, San Antonio, TX, USA
| | - Y Saito
- Institute for Space and Astronautical Sciences, Sagamihara, Japan
| | - V Coffey
- NASA, Marshall Space Flight Center, Huntsville, AL, USA
| | - M Chandler
- NASA, Marshall Space Flight Center, Huntsville, AL, USA
| |
Collapse
|
26
|
Goldman M, Coté J, Hannon J, Clarke G, Ochoa-Garay G, Pambrun C. RHD genotyping for prenatal patients with a serologic weak D phenotype. Transfus Med Rev 2015. [DOI: 10.1016/j.tmrv.2015.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
27
|
Goldman M, Land K, Robillard P, Wiersum-Osselton J. Development of standard definitions for surveillance of complications related to blood donation. Vox Sang 2015; 110:185-8. [PMID: 26361365 DOI: 10.1111/vox.12323] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2015] [Revised: 07/20/2015] [Accepted: 07/21/2015] [Indexed: 11/28/2022]
Abstract
Standard definitions of donor reactions allow each blood establishment to monitor donor adverse events and compare with other organizations to develop best practices. The ISBT Haemovigilance Working Party leads a multi-organizational effort to update the 2008 ISBT standard for surveillance of complications related to blood donation. Revised definitions have been developed and endorsed by the ISBT, AABB, International Haemovigilance Network (IHN) and other international organizations.
Collapse
Affiliation(s)
- M Goldman
- Canadian Blood Services, Ottawa, ON, Canada
| | - K Land
- Blood Systems Inc., Scottsdale, AZ, USA
| | | | | |
Collapse
|
28
|
Nir H, Berkovitch M, Youngster I, Kozer E, Goldman M, Abu-Kishk I. Effect of hyperbaric oxygen therapy on amphotericin-B induced acute renal failure in rats. MINERVA UROL NEFROL 2015; 67:97-102. [PMID: 25847867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
AIM Acute renal injury may occur after amphotericin B (AmB) administration. The hypothesized injury mechanism is renal vasoconstriction and direct toxic damage. Hyperbaric oxygen therapy (HBO) is indicated for treatment of many ischemic events but not for acute renal failure (ARF). The aim of this study was to investigate the role of HBO therapy in AmB induced ARF. METHODS ARF was induced in 41 Sprague-Dawley rats by a single dose of 75 mg/kg AmB. The rats were randomly divided into two groups; one group was treated with daily HBO for 3 consecutive days. The control group received no HBO treatment. Parameters of renal function were taken on the 5th day after AmB administration. RESULTS Forty-one rats were treated with AmB, 21 received HBO and 20 served as controls. Body weight loss following the administration of AmB was 13.5+14.7% in the HBO treated rats, as opposed to 24.6+5% in the control group (P=0.004). Serum creatinine and urea were 0.49+0.13 mg/dL and 200.63+87.82 mg/dL in the treatment group and 0.70+0.22 mg/dL and 368.01+169.35 mg/dL, respectively in the control (P=0.001). CONCLUSION In this model of AmB-induced ARF, HBO treatment alleviated renal injury as reflected by changes in serum creatinine and urea levels.
Collapse
Affiliation(s)
- H Nir
- Pediatric Division, Assaf Harofeh Medical Center Zerifin 70300, Sackler Faculty of Medicine Tel Aviv University, Israel -
| | | | | | | | | | | |
Collapse
|
29
|
O'Brien SF, Osmond L, Choquet K, Yi QL, Goldman M. Donor attention to reading materials. Vox Sang 2015; 109:336-42. [DOI: 10.1111/vox.12298] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2015] [Revised: 03/24/2015] [Accepted: 04/11/2015] [Indexed: 11/27/2022]
Affiliation(s)
- S. F. O'Brien
- Canadian Blood Services; Ottawa ON Canada
- School of Epidemiology, Public Health and Preventive Medicine; University of Ottawa; Ottawa ON Canada
| | - L. Osmond
- Canadian Blood Services; Ottawa ON Canada
| | - K. Choquet
- Canadian Blood Services; Ottawa ON Canada
| | - Q.-L. Yi
- Canadian Blood Services; Ottawa ON Canada
- School of Epidemiology, Public Health and Preventive Medicine; University of Ottawa; Ottawa ON Canada
| | - M. Goldman
- Canadian Blood Services; Ottawa ON Canada
- Department of Pathology & Laboratory Medicine; University of Ottawa; Ottawa ON Canada
| |
Collapse
|
30
|
Goldman M. [Homage to Professor Andre Govaerts]. Rev Med Brux 2015; 36:190-191. [PMID: 26372984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|
31
|
Bobrie G, Noël LH, Savage CO, Pochet JM, Pirson Y, Goldman M, Dechelette E, Moulonguet-Doleris L, Lockwood CM, Grünfeld JP. Kidney transplantation in Alport's syndrome and related diseases. Contrib Nephrol 2015; 80:76-80. [PMID: 2282824 DOI: 10.1159/000418630] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- G Bobrie
- Département de Néphrologie, Hôpital Necker, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Goldman M, Nortier J, Dhaene M, Amraoui Z, Vanherweghem JL. Fate of beta-2-microglobulin during dialysis on polysulfone and AN69 membranes. Contrib Nephrol 2015; 74:127-31. [PMID: 2702129 DOI: 10.1159/000417481] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- M Goldman
- Département de Néphrologie, Dialyse et Transplantation, Hôpital Erasme, Université Libre de Bruxelles, Belgique
| | | | | | | | | |
Collapse
|
33
|
Nortier J, Abramowicz D, Najdovski T, Kinnaert P, Vanherweghem JL, Goldman M, Deschodt-Lanckman M. Urinary endopeptidase 24.11 as a new marker of proximal tubular injury. Preliminary study in kidney transplant recipients. Contrib Nephrol 2015; 101:169-76. [PMID: 8467672 DOI: 10.1159/000422127] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Affiliation(s)
- J Nortier
- Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale, Faculté de Médecine, Université Libre de Bruxelles, Belgium
| | | | | | | | | | | | | |
Collapse
|
34
|
Affiliation(s)
- M. Goldman
- Donor & Clinical Services; Canadian Blood Services; Ottawa ON Canada
| |
Collapse
|
35
|
Hsiao PY, Fung J, Mitchell D, Hartman T, Goldman M. Dietary Quality in Nulliparous Women Planning Pregnancy: Results from the ISIS Study. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.590.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Pao Ying Hsiao
- Dept. of Food and Nutrition Indiana University of PennsylvaniaIndianaPAUnited States
| | - June Fung
- Dept. of Obstetrics and GynecologyGeisel School of Medicine Dartmouth CollegeHanoverNHUnited States
| | - Diane Mitchell
- Dept. of Nutritional Sciences The Pennsylvania State UniversityUniversity ParkPAUnited States
| | - Terryl Hartman
- Dept. of Epidemiology Emory UniversityAtlantaGAUnited States
| | - Marlene Goldman
- Dept. of Obstetrics and GynecologyGeisel School of Medicine Dartmouth CollegeHanoverNHUnited States
| |
Collapse
|
36
|
Leidy NK, Sexton CC, Jones PW, Notte SM, Monz BU, Nelsen L, Goldman M, Murray LT, Sethi S. Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax 2014; 69:443-9. [PMID: 24595666 PMCID: PMC3995276 DOI: 10.1136/thoraxjnl-2013-204428] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2013] [Revised: 01/31/2014] [Accepted: 02/04/2014] [Indexed: 01/24/2023]
Abstract
BACKGROUND Although respiratory symptoms are characteristic features of COPD, there is no standardised method for quantifying their severity in stable disease. OBJECTIVE To evaluate the EXACT-Respiratory Symptom (E-RS) measure, a daily diary comprising 11 of the 14 items in the Exacerbations of Chronic Pulmonary Disease Tool (EXACT). METHODS Qualitative: patient focus group and interviews to address content validity. Quantitative: secondary data analyses to test reliability and validity. RESULTS Qualitative: n=84; mean (SD) age 65 (10) years, FEV1 1.2(0.4) L; 44% male. Subject descriptions of their respiratory symptoms were consistent with E-RS content and structure. Quantitative: n=188; mean (SD) age 66 (10) years, FEV1 1.2(0.5) L; 50% male. Factor analysis (FA) showed 3 subscales: RS-Breathlessness, RS-Cough & Sputum, and RS-Chest Symptoms; second-order FA supported a general factor and total score. Reliability (total and subscales): 0.88, 0.86, 0.73, 0.81; 2-day test-retest ICC: 0.90, 0.86, 0.87, 0.82, respectively. VALIDITY Total scores correlated significantly (p < 0.0001) with SGRQ Total (r=0.75), Symptoms (r=0.66), Activity (r=0.57), Impact (r=0.70) scores; subscale correlations were also significant (r=0.26, p < 0.05 (RS-Chest Symptoms with Activity) to r=0.69, p < 0.0001 (RS-Cough & Sputum with Symptoms). RS-Breathlessness correlated with rescue medication use (r=0.32, p < 0.0001), clinician-reported mMRC (r=0.33, p < 0.0001), and FEV1% predicted (r=-0.17, p < 0.05). E-RS scores differentiated groups based on chronic bronchitis diagnosis (p < 0.01-0.001), smoking status (p < 0.05-0.001), and rescue medication use (p < 0.05-0.0001). CONCLUSIONS Results suggest the RS-Total is a reliable and valid instrument for evaluating respiratory symptom severity in stable COPD. Further study of sensitivity to change is warranted.
Collapse
|
37
|
Osterholzer DA, Goldman M. Dolutegravir: A Next-Generation Integrase Inhibitor for Treatment of HIV Infection. Clin Infect Dis 2014; 59:265-71. [DOI: 10.1093/cid/ciu221] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Pietersz RNI, Reesink HW, Panzer S, Oknaian S, Kuperman S, Gabriel C, Rapaille A, Lambermont M, Deneys V, Sondag D, Ramírez-Arcos S, Goldman M, Delage G, Bernier F, Germain M, Vuk T, Georgsen J, Morel P, Naegelen C, Bardiaux L, Cazenave JP, Dreier J, Vollmer T, Knabbe C, Seifried E, Hourfar K, Lin CK, Spreafico M, Raffaele L, Berzuini A, Prati D, Satake M, de Korte D, van der Meer PF, Kerkhoffs JL, Blanco L, Kjeldsen-Kragh J, Svard-Nilsson AM, McDonald CP, Symonds I, Moule R, Brailsford S, Yomtovian R, Jacobs MR. Bacterial contamination in platelet concentrates. Vox Sang 2014; 106:256-83. [DOI: 10.1111/vox.12098] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
39
|
Affiliation(s)
- P. Ley
- Research Unit in Doctor-Patient Communication, Department of Psychiatry, University of Liverpool
| | | | - P. W. Bradshaw
- Research Unit in Doctor-Patient Communication, Department of Psychiatry, University of Liverpool
| | - J. A. Kincey
- Research Unit in Doctor-Patient Communication, Department of Psychiatry, University of Liverpool
| | - C. M. Walker
- Research Unit in Doctor-Patient Communication, Department of Psychiatry, University of Liverpool
| |
Collapse
|
40
|
Garlich FM, Goldman M, Pepe J, Nelson LS, Allan MJ, Goldstein DA, Goldfarb DS, Hoffman RS. Hemodialysis clearance of glyphosate following a life-threatening ingestion of glyphosate-surfactant herbicide. Clin Toxicol (Phila) 2014; 52:66-71. [PMID: 24400933 DOI: 10.3109/15563650.2013.870344] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
CONTEXT Ingestion of glyphosate-surfactant herbicides (GlySH) can result in acute kidney injury, electrolyte abnormalities, acidosis, cardiovascular collapse, and death. In severe toxicity, the use of hemodialysis is reported, but largely unsupported by kinetic analysis. We report the dialysis clearance of glyphosate following a suicidal ingestion of a glyphosate-containing herbicide. CASE DETAILS A 62-year-old man was brought to the emergency department (ED) 8.5 h after drinking a bottle of commercial herbicide containing a 41% solution of glyphosate isopropylamine, in polyoxyethyleneamine (POEA) surfactant and water. He was bradycardic and obtunded with respiratory depression necessitating intubation and mechanical ventilation. Initial laboratory results were significant for the following: pH, 7.11; PCO2, 64 mmHg; PO2, 48 mmHg; potassium, 7.8 mEq/L; Cr 3.3, mg/dL; bicarbonate, 22 mEq/L; anion gap, 18 mEq/L; and lactate, 7.5 mmol/L. Acidosis and hyperkalemia persisted despite ventilation and fluid resuscitation. The patient underwent hemodialysis 16 h post ingestion, after which he demonstrated resolution of acidosis and hyperkalemia, and improvement in clinical status. Serum glyphosate concentrations were drawn prior to, during, and after hemodialysis. The extraction ratio and hemodialysis clearance were calculated to be 91.8% and 97.5 mL/min, respectively. DISCUSSION We demonstrate the successful clearance of glyphosate using hemodialysis, with corresponding clinical improvement in a patient with several poor prognostic factors (advanced age, large volume ingested, and impaired consciousness). The effects of hemodialysis on the surfactant compound are unknown. Hemodialysis can be considered when severe acidosis and acute kidney injury complicate ingestion of glyphosate-containing products.
Collapse
Affiliation(s)
- F M Garlich
- Poison and Drug Information Service, Alberta Health Services , Calgary, Alberta , Canada
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Chien AJ, Duralde E, Kao CN, McCulloch C, Melisko M, Rugo HS, Cedars M, Goldman M, Rosen M. Abstract P3-08-18: Association of tamoxifen use and ovarian aging in patients with invasive or pre-invasive breast cancer. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p3-08-18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The use of tamoxifen has been shown to delay the recovery of chemotherapy-induced amenorrhea, however the independent impact of long-term endocrine therapy on ovarian aging is not known, and to our knowledge, has never been directly investigated. Understanding the effect of endocrine therapy on ovarian aging will help breast cancer patients of reproductive age make more informed and empowered decisions regarding their treatment. The aim of this study is to explore the relationship between tamoxifen therapy and age onset of menopause.
Methods: We conducted a retrospective cohort study using patients identified through the UCSF Cancer Registry and UCSF SPORE database. Women who were diagnosed with Stage 1-3 invasive or in situ breast cancer between 1985 and 2011, who were premenopausal at the time of diagnosis and who did not receive systemic chemotherapy were included. Patients with recurrent disease and prior ovarian surgery were excluded. Eligibility was confirmed by telephone, and online or paper surveys were distributed to eligible subjects only. Age onset of menopause was the primary endpoint of the study and was defined as the age at which a woman had her last period and no menses for 12 months. Age onset of menopause was assessed through surveys. The primary analysis compared age onset of menopause between subjects who received tamoxifen for any duration and control subjects who never received tamoxifen. Secondary analyses were performed using a Cox proportional hazards model to determine whether duration of tamoxifen exposure and age of tamoxifen initiation impacted age onset of menopause in subjects treated with tamoxifen.
Results: A total of 1137 potential subjects believed to meet eligibility criteria were identified and called, and 649 subjects were reached. Eligibility was confirmed by phone in 340 subjects. A total of 336 subjects consented to participate in the study, and 262 (78%) completed and returned the survey. 227 subjects were included in the primary analysis of which 110 subjects received prior tamoxifen, and 117 subjects received no prior tamoxifen. At the time of the survey, 16.3% vs. 20.2% of patients under age 50 that were exposed and not exposed to tamoxifen entered menopause, respectively. The median age onset of menopause was 50.94 and 51.34 for the tamoxifen and no tamoxifen groups, respectively. The hazard ratio between these groups was 1.077 which was not statistically significant (p = 0.6917). No association (p = 0.55) was found between the duration of tamoxifen use and the age onset of menopause. When controlling for tamoxifen duration, there was no significant difference (p = 0.93) in age onset of menopause between subjects who initiated tamoxifen prior to age 45 and those who initiated at age 45 or older.
Conclusion: These data suggest that tamoxifen alone is not associated with an earlier age onset of menopause, and that tamoxifen use, in the absence of systemic chemotherapy, is unlikely to significantly accelerate ovarian aging.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P3-08-18.
Collapse
Affiliation(s)
- AJ Chien
- University of California, San Francisco, San Francisco, CA
| | - E Duralde
- University of California, San Francisco, San Francisco, CA
| | - C-N Kao
- University of California, San Francisco, San Francisco, CA
| | - C McCulloch
- University of California, San Francisco, San Francisco, CA
| | - M Melisko
- University of California, San Francisco, San Francisco, CA
| | - HS Rugo
- University of California, San Francisco, San Francisco, CA
| | - M Cedars
- University of California, San Francisco, San Francisco, CA
| | - M Goldman
- University of California, San Francisco, San Francisco, CA
| | - M Rosen
- University of California, San Francisco, San Francisco, CA
| |
Collapse
|
42
|
Germain M, Robillard P, Delage G, Goldman M. Allowing blood donation from men who had sex with men more than 5 years ago: a model to evaluate the impact on transfusion safety in Canada. Vox Sang 2013; 106:372-5. [DOI: 10.1111/vox.12109] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
| | | | - G. Delage
- Héma-Québec; Saint-Laurent QC Canada
| | - M. Goldman
- Canadian Blood Services; Ottawa ON Canada
| |
Collapse
|
43
|
Shalem T, Bistritzer T, Goldman M. [How to choose a resident?]. Harefuah 2013; 152:615-616. [PMID: 24450038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
44
|
Stein AA, Goldman M, McPherson G, Snopkowski RS, Paunovitch E. An Accessory Solid-State Thermostat for Autotechnicon Paraffin Baths. J Histotechnol 2013. [DOI: 10.1179/his.1980.3.4.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
45
|
O'Brien SF, Goldman M, Scalia V, Yi QL, Fan W, Xi G, Dines IR, Fearon MA. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med 2013; 23:358-66. [PMID: 23859527 DOI: 10.1111/tme.12057] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2013] [Revised: 06/11/2013] [Accepted: 06/16/2013] [Indexed: 12/11/2022]
Abstract
OBJECTIVES Blood donors in Canada have been tested for Human T-Cell Lymphotropic Virus (HTLV) since 1990. We report the epidemiology, risk factors and lookback/traceback of HTLV-positive donors/recipients. METHODS The annual HTLV rate was calculated from 1990 to 2010. Residual risk was estimated as the product of incidence and window period. Twenty-nine HTLV-positive donors and 116 matched controls (ratio 1 : 4) were interviewed about risk factors. For HTLV-positive donations, lookback investigations involved identification of all previous donations, and attempting to locate and test recipients. Traceback was initiated when transfusion transmission was queried for HTLV-positive blood recipients. All donors of products that the recipient received were identified, with an attempt to locate and test them. RESULTS The HTLV rate decreased from 9.35 per 100,000 donations in 1990 to 1.11 in 2010. The residual risk of infection was 1 in 7.6 million donations. In logistic regression birth overseas (OR 18.7), history of sexually transmitted diseases (OR 32.9), sex with unknown background (OR 5.4) and blood transfusion (OR 8.9) were significant predictors. In the lookback study, of 109 HTLV-positive donors, 508 components were transfused, of whom 147 recipients were tested and 18 (12%) were positive. All were transfused prior to the implementation of donor testing. Twenty-three traceback investigations were requested involving 324 transfused untested products,of whom 219 (67.6%) of donors were tested and 13 (6%) were positive for HTLV. CONCLUSIONS With testing of the blood supply, the risk from HTLV is very low and while most HTLV-positive donors have risk factors, deferrable risk is rare.
Collapse
Affiliation(s)
- S F O'Brien
- Canadian Blood Services, Ottawa, ON, Canada; Department of Epidemiology & Community Medicine
| | | | | | | | | | | | | | | |
Collapse
|
46
|
Riethmueller J, Goldman M, Turay P. 90 Inhalation of colistimethate dry powder (Colobreathe) results in negligible systemic exposure. J Cyst Fibros 2013. [DOI: 10.1016/s1569-1993(13)60232-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
47
|
Germain M, Delage G, Robillard P, Goldman M. Interdiction temporaire au don de sang des hommes ayant eu des relations sexuelles avec d’autres hommes : impact sur le risque de transmission du VIH par transfusion au Canada. Transfus Clin Biol 2013. [DOI: 10.1016/j.tracli.2013.03.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
48
|
Lemaître PH, Vokaer B, Charbonnier LM, Iwakura Y, Field KA, Estenne M, Goldman M, Leo O, Remmelink M, Le Moine A. Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease. Am J Transplant 2013; 13:611-20. [PMID: 23331973 DOI: 10.1111/ajt.12067] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2012] [Revised: 11/16/2012] [Accepted: 11/17/2012] [Indexed: 01/25/2023]
Abstract
Calcineurin-inhibitor refractory bronchiolitis obliterans (BO) represents the leading cause of late graft failure after lung transplantation. T helper (Th)2 and Th17 lymphocytes have been associated with BO development. Taking advantage of a fully allogeneic trachea transplantation model in mice, we addressed the pathogenicity of Th cells in obliterative airway disease (OAD) occurring in cyclosporine A (CsA)-treated recipients. We found that CsA prevented CD8(+) T cell infiltration into the graft and downregulated the Th1 response but affected neither Th2 nor Th17 responses in vivo. In secondary mixed lymphocyte cultures, CsA dramatically decreased donor-specific IFN-γ production, enhanced IL-17 production and did not affect IL-13. As CD4(+) depletion efficiently prevented OAD in CsA-treated recipients, we further explored the role of Th2 and Th17 immunity in vivo. Although IL-4 and IL-17 deficient untreated mice developed an OAD comparable to wild-type recipients, a single cytokine deficiency afforded significant protection in CsA-treated recipients. In conclusion, CsA treatment unbalances T helper alloreactivity and favors Th2 and Th17 as coexisting pathways mediating chronic rejection of heterotopic tracheal allografts.
Collapse
Affiliation(s)
- P H Lemaître
- Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Goldman M, Resz I, Cote J, Ochoa G, Angus N. Identifying D-positive donors using a second automated testing platform. Immunohematology 2013; 29:97-100. [PMID: 24325169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Because of the variability of D expression, one method may be inadequate to correctly classify donors with variant RHD alleles. We evaluated the use of a solid -phase automated platform (ImmucorGamma Galileo) to confirm D- test results obtained on first-time donors on the Beckman Coulter PK7300 automated microplate test system. Samples with discordant results were analyzed by serologic tube methods, RHD genotyping using the BLOODchip platform (Progenika) and, if necessary, sequencing. We estimated the number of cases of alloimmunization in women younger than 50 years likelyto be prevented by the addition of Galileo testing. From May 2011 to May 2012, 910,220 donor samples were tested; 15,441 were first-time donors with concordant D- results. Five donors tested D- on the PK7300 and weak D+ on the Galileo; one was found to be a false positive on further testing. On manual testing, the other four donors had positive indirect antiglobulin test results with one to three of the antisera used and were C+. On BLOODchip testing, two donors were classified as D+, and two were assigned a "no call". D variants included weak D type 67, weak D type 9, and two novel variants. Approximately 10 percent of D- units are transfused to women younger that 50 years. Assuming an alloimmunization rate of 30 percent, use of the Galileo would prevent approximately one alloimmunization every 5 to 6 years in this patient group. We conclude that the yield of preventing alloimmunization in this population by adding a second automated seologic testing platform is very low.
Collapse
Affiliation(s)
- M Goldman
- MD (corresponding author), Executive Medical Director, Donor and Transplantation Services
| | | | | | | | | |
Collapse
|
50
|
Abstract
Interleukin-10 (IL-10) is a potent anti-inflammatory and immunosuppressive cytokine secreted by several cell types. Most anti-inflammatory effects of IL-10 are caused by its ability to deactivate macrophages and monocytes, whereas its immunosuppressive properties are due to functional inhibition of both antigen-presenting cells and T cells. On the other hand, IL-10 also exerts immunostimulatory effects, especially on B cells, CD8+ cytotoxic T cells and natural killer cells. In vivo administration of recombinant IL-10 (rIL-10) efficiently prevents experimental septic shock induced by endotoxin, staphylococcal superantigen or cecal ligation and puncture, as well as experimental autoimmune diseases mediated by T helper type 1 (T(H)1) cells and other inflammatory disorders. rIL-10 exerts paradoxical effects in cancer models, where it promotes tumour rejection, probably due to its stimulatory properties on cytotoxic cells. On the other hand, rIL-10 increases the severity of experimental infections caused by fungi or bacteria, and enhances systemic autoimmune features in mice with spontaneous lupus syndrome. Although the therapeutic potential of rIL-10 in human diseases seems promising, the multiple facets of rIL-10 in experimental immunopathology indicate that the success of clinical trials with rIL-10 will depend both on the appropriate selection of the patient populations to be treated and on the early detection of possible adverse effects.
Collapse
Affiliation(s)
- M Goldman
- Department of Immunology, Hôpital Erasme, and Laboratory of Experimental Immunology, Université Libre de Bruxelles, Bruxelles, Belgium
| | | | | |
Collapse
|